Ascendis Pharma A/S (ASND)
253.38
+1.43
(+0.57%)
USD |
NASDAQ |
Aug 25, 16:00
253.38
0.00 (0.00%)
After-Hours: 19:29
Ascendis Pharma Total Liabilities (Quarterly) : 971.27M for June 30, 2026
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 971.27M |
| March 31, 2026 | 1.746B |
| December 31, 2025 | 1.721B |
| September 30, 2025 | 1.561B |
| June 30, 2025 | 1.497B |
| March 31, 2025 | 1.352B |
| December 31, 2024 | 1.331B |
| September 30, 2024 | 1.329B |
| June 30, 2024 | 1.157B |
| March 31, 2024 | 1.124B |
| December 31, 2023 | 1.073B |
| September 30, 2023 | 1.002B |
| June 30, 2023 | 828.05M |
| March 31, 2023 | 868.15M |
| December 31, 2022 | 881.96M |
| September 30, 2022 | 805.14M |
| June 30, 2022 | 751.67M |
| March 31, 2022 | 783.79M |
| December 31, 2021 | 228.90M |
| September 30, 2021 | 245.32M |
| June 30, 2021 | 194.92M |
| March 31, 2021 | 190.98M |
| December 31, 2020 | 172.62M |
| September 30, 2020 | 110.86M |
| June 30, 2020 | 93.74M |
| Date | Value |
|---|---|
| March 31, 2020 | 79.63M |
| December 31, 2019 | 89.37M |
| September 30, 2019 | 80.71M |
| June 30, 2019 | 104.86M |
| March 31, 2019 | 50.84M |
| December 31, 2018 | 44.49M |
| September 30, 2018 | 36.04M |
| June 30, 2018 | 42.78M |
| March 31, 2018 | 21.42M |
| December 31, 2017 | 28.54M |
| September 30, 2017 | 23.51M |
| June 30, 2017 | 18.17M |
| March 31, 2017 | 19.18M |
| December 31, 2016 | 14.19M |
| September 30, 2016 | 13.88M |
| June 30, 2016 | 13.14M |
| March 31, 2016 | 12.27M |
| December 31, 2015 | 12.43M |
| September 30, 2015 | 10.66M |
| June 30, 2015 | 13.80M |
| March 31, 2015 | |
| December 31, 2014 | 15.56M |
| September 30, 2014 | 16.71M |
| June 30, 2014 | 21.88M |
| March 31, 2014 |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Evaxion AS | 9.849M |
| Genmab A/S | 6.558B |
| Zealand Pharma A/S | 269.50M |
| Cellectis SA | 226.30M |
| BioMarin Pharmaceutical, Inc. | 5.402B |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 2.614B |
| Shareholders Equity (Quarterly) | 1.642B |
| Debt to Equity Ratio | 0.3133 |
| Current Ratio | 2.991 |
| Net Debt Paydown Yield | 0.46% |